González P,Tunon M J,Lopez P.Hepatic disposition of organic anions in rats infested with Fasciola hepatica[J].Experimental Parasitology.1991,73:396-402
[2]
Tufenkji A E,Alvinerie M,Pineau T.Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep[J].Xenobiotica.1988,18:357-364
[3]
Danhof M,Breimer D D,Stobo J D.Studies of different metabolic pathways of antipyrine in man:Oral versus I.V.administration and the influence of urinary collection time[J].European Journal of Clinical Pharmacology.1982,21:433-441
[4]
John V,St Peter,Yusuf Abul-Hajj.The pharmacokinetics of antipyrine and three of its metabolites in the raxbit:intravenous administration of pure metabolites[J].Pharmaceutical Research.1991,8(12):1470-1476
[5]
Elsheikh H A,Ali B H,Homeida A M.The effects of fascioliasis on the activities of some drug-metabolizing enzymes in desert sheep liver[J].British Veterinary Journal.1992,148:249-257
[6]
Danhof M,Groot-van der Vis E,Breimer D D.Assay of antipyrine and its metabolites in plasma,saliva and urine by high-performance liquid chromatography and some preliminary results in man[J].Pharmacology.1979,18:210-223
[7]
Buppodom P,Koga N,Yamada H.Studies on rat liver cytochrome P-450S involved in the metabolism of antipyrine[J].Biochemistry Pharmacology.1986,35:1404-1406
[8]
Palette C,Advenier C,Pelus L M.Determination of antipyrine sulphoconjgates in isolated cultured rat hepatocytes[J].Xenobiotica.1993,23(2):181-191
[9]
Biro-Sauveur B,Eeckhoutte C,Keppler D.Comparison of hepatic and extraphepatic drug-metabolizing enzyme activities in rats given single or multiple challenge infections with Fasciola hepatica[J].International Journal for Parasitology.1995,25:1193-1200
